<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-13T02:17:54Z</responseDate>
  <request identifier="oai:aino.repo.nii.ac.jp:00000320" metadataPrefix="jpcoar_2.0" verb="GetRecord">https://aino.repo.nii.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:aino.repo.nii.ac.jp:00000320</identifier>
        <datestamp>2025-09-11T06:11:07Z</datestamp>
        <setSpec>7:37</setSpec>
      </header>
      <metadata>
        <jpcoar:jpcoar xmlns:datacite="https://schema.datacite.org/meta/kernel-4/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcndl="http://ndl.go.jp/dcndl/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:jpcoar="https://github.com/JPCOAR/schema/blob/master/2.0/" xmlns:oaire="http://namespace.openaire.eu/schema/oaire/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rioxxterms="http://www.rioxx.net/schema/v2.0/rioxxterms/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns="https://github.com/JPCOAR/schema/blob/master/2.0/" xsi:schemaLocation="https://github.com/JPCOAR/schema/blob/master/2.0/jpcoar_scm.xsd">
          <dc:title xml:lang="en">Interstitial pneumonia and de-novo onset of asthma induced by leuprorelin acetate for prostate cancer</dc:title>
          <jpcoar:creator>
            <jpcoar:creatorName xml:lang="en">Yamasaki, Hidetomo</jpcoar:creatorName>
            <jpcoar:familyName xml:lang="en">Yamasaki</jpcoar:familyName>
            <jpcoar:givenName xml:lang="en">Hidetomo</jpcoar:givenName>
          </jpcoar:creator>
          <jpcoar:creator>
            <jpcoar:creatorName xml:lang="en">Nakajima, Hideto</jpcoar:creatorName>
            <jpcoar:familyName xml:lang="en">Nakajima</jpcoar:familyName>
            <jpcoar:givenName xml:lang="en">Hideto</jpcoar:givenName>
          </jpcoar:creator>
          <jpcoar:creator>
            <jpcoar:creatorName xml:lang="en">Tanaka, Toshifumi</jpcoar:creatorName>
            <jpcoar:familyName xml:lang="en">Tanaka</jpcoar:familyName>
            <jpcoar:givenName xml:lang="en">Toshifumi</jpcoar:givenName>
            <jpcoar:affiliation/>
          </jpcoar:creator>
          <jpcoar:creator>
            <jpcoar:creatorName xml:lang="en">Ohsawa, Nakaaki</jpcoar:creatorName>
            <jpcoar:familyName xml:lang="en">Ohsawa</jpcoar:familyName>
            <jpcoar:givenName xml:lang="en">Nakaaki</jpcoar:givenName>
            <jpcoar:affiliation/>
          </jpcoar:creator>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">leuprorelin acetate</jpcoar:subject>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">interstitial pneumonia</jpcoar:subject>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">chemokine receptor</jpcoar:subject>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">Th 1/Th 2 balance</jpcoar:subject>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">bronchial asthma</jpcoar:subject>
          <jpcoar:subject xml:lang="en" subjectScheme="Other">prostate cancer</jpcoar:subject>
          <datacite:description xml:lang="en" descriptionType="Abstract">We describe herein the first report of side effects induced by leuprorelin acetate (LA) administration. A 70-year-old man, with idiopathic pulmonary fibrosis (IPF), vasospastic angina, diabetes mellitus type 2, and arteriosclerosis obliterans was suffering from prostate cancer. LA administration (drug-) induced interstitial pneumonia based on IPF and the de-novo onset of bronchial asthma, both of which are thought to be Th 2-related diseases. Using 3-color flow cytometry, we analyzed the chemokine receptors CD4+CXCR3+/CD3+ and CD4+CCR4+/CD3+, and found that the CXCR3/CCR4 ratio changed in the Th 2 pattern. It is important to be careful with LA administration, especially for underlying Th 2-related diseases, and clinicians should fully understand the possibilities of LA-inducing de-novo Th 1/Th 2-driven autoimmune diseases.</datacite:description>
          <datacite:date dateType="Issued">2006</datacite:date>
          <dc:language>eng</dc:language>
          <dc:type rdf:resource="http://purl.org/coar/resource_type/c_6501">departmental bulletin paper</dc:type>
          <jpcoar:identifier identifierType="URI">https://aino.repo.nii.ac.jp/records/320</jpcoar:identifier>
          <jpcoar:sourceIdentifier identifierType="PISSN">1348480X</jpcoar:sourceIdentifier>
          <jpcoar:sourceTitle xml:lang="en">AINO JOURNAL</jpcoar:sourceTitle>
          <jpcoar:volume>5</jpcoar:volume>
          <jpcoar:issue>1</jpcoar:issue>
          <jpcoar:numPages>4</jpcoar:numPages>
          <jpcoar:pageStart>73</jpcoar:pageStart>
          <jpcoar:pageEnd>76</jpcoar:pageEnd>
          <jpcoar:file>
            <jpcoar:URI label="KJ00005223091.pdf">https://aino.repo.nii.ac.jp/record/320/files/KJ00005223091.pdf</jpcoar:URI>
            <jpcoar:mimeType>application/pdf</jpcoar:mimeType>
            <jpcoar:extent>554.6 kB</jpcoar:extent>
            <datacite:date dateType="Available">2019-03-27</datacite:date>
          </jpcoar:file>
        </jpcoar:jpcoar>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
